LiveASX is an independent website and is not affiliated with, endorsed by, or associated with ASX Limited.

TELIX PHARMACEUTICALS LIMITED (TLX)

Health care · Historical news and closing prices

Telix Director Adds Shares Through On-Market Purchase

TLX · Health care · 2026-10-27

Telix Pharmaceuticals director Dr Christian Behrenbruch bought 38,750 ordinary shares on market for approximately $13 per share. His indirect holding through the Behrenbruch Family Trust increased by the same amount, while his reported direct holdings were unchanged.

Closing price · 2026-10-27: $12.79 · -0.47%

Telix Directors Report Separate On-Market Share Purchases

TLX · Health care · 2026-10-26

Telix Pharmaceuticals directors David Gill and William Jellison reported separate Nasdaq on-market purchases of American Depositary Shares, with no securities disposed. Gill’s holding rose from 22,000 to 25,250 ADS, while Jellison reported 25,000 ADS held jointly with Joanne Jellison.

Closing price · 2026-10-26: $12.85 · -2.58%